Paxman Future Growth
Future criteria checks 6/6
Paxman is forecast to grow earnings and revenue by 57.2% and 30.1% per annum respectively. EPS is expected to grow by 57.3% per annum. Return on equity is forecast to be 41.8% in 3 years.
Key information
57.2%
Earnings growth rate
57.3%
EPS growth rate
Medical Equipment earnings growth | 24.7% |
Revenue growth rate | 30.1% |
Future return on equity | 41.8% |
Analyst coverage | Low |
Last updated | 26 Feb 2024 |
Recent future growth updates
Recent updates
After Leaping 28% Paxman AB (publ) (STO:PAX) Shares Are Not Flying Under The Radar
Jul 18Even With A 29% Surge, Cautious Investors Are Not Rewarding Paxman AB (publ)'s (STO:PAX) Performance Completely
May 24Does Paxman (STO:PAX) Have A Healthy Balance Sheet?
Dec 23Paxman (STO:PAX) Shareholders Will Want The ROCE Trajectory To Continue
Aug 25Paxman AB (publ) (STO:PAX) Could Be Riskier Than It Looks
Jun 01Does Paxman (STO:PAX) Have A Healthy Balance Sheet?
Nov 20Is Paxman (STO:PAX) A Risky Investment?
Mar 07Paxman (STO:PAX) Is Making Moderate Use Of Debt
Mar 15Are Insiders Buying Paxman AB (publ) (STO:PAX) Stock?
Jan 22Reflecting on Paxman's (STO:PAX) Share Price Returns Over The Last Year
Dec 18Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 537 | 123 | 76 | 102 | 1 |
12/31/2025 | 401 | 84 | 55 | 78 | 1 |
12/31/2024 | 292 | 34 | 31 | 50 | 1 |
3/31/2024 | 236 | 24 | 1 | 28 | N/A |
12/31/2023 | 221 | 8 | -10 | 16 | N/A |
9/30/2023 | 208 | 1 | -28 | 8 | N/A |
6/30/2023 | 188 | -2 | -31 | 5 | N/A |
3/31/2023 | 173 | -7 | -38 | 4 | N/A |
12/31/2022 | 157 | -10 | -33 | 3 | N/A |
9/30/2022 | 143 | -2 | -20 | 4 | N/A |
6/30/2022 | 125 | -12 | -16 | 8 | N/A |
3/31/2022 | 111 | -18 | -27 | -3 | N/A |
12/31/2021 | 105 | -13 | -28 | -4 | N/A |
9/30/2021 | 93 | -23 | -14 | -7 | N/A |
6/30/2021 | 87 | -21 | -19 | -12 | N/A |
3/31/2021 | 80 | -22 | -16 | -9 | N/A |
12/31/2020 | 83 | -19 | -15 | -8 | N/A |
9/30/2020 | 90 | -6 | -22 | -1 | N/A |
6/30/2020 | 96 | -1 | -18 | 2 | N/A |
3/31/2020 | 102 | 6 | -15 | 2 | N/A |
12/31/2019 | 96 | 3 | -18 | 3 | N/A |
9/30/2019 | 90 | -4 | -7 | -1 | N/A |
6/30/2019 | 83 | -5 | -19 | 0 | N/A |
3/31/2019 | 75 | -6 | -18 | 2 | N/A |
12/31/2018 | 69 | -7 | -18 | 0 | N/A |
9/30/2018 | 58 | -9 | -24 | 1 | N/A |
6/30/2018 | 50 | -10 | -20 | -7 | N/A |
3/31/2018 | 43 | -9 | -25 | -8 | N/A |
12/31/2017 | 36 | -7 | N/A | -7 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PAX's forecast earnings growth (57.2% per year) is above the savings rate (1.1%).
Earnings vs Market: PAX's earnings (57.2% per year) are forecast to grow faster than the Swedish market (15.8% per year).
High Growth Earnings: PAX's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: PAX's revenue (30.1% per year) is forecast to grow faster than the Swedish market (1.1% per year).
High Growth Revenue: PAX's revenue (30.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: PAX's Return on Equity is forecast to be very high in 3 years time (41.8%).